Our research is focused on adverse drug interactions, anticancer drug resistance, and anticancer drug discovery. We are interested in understanding the mechanistic role of xenobiotic receptors, drug-metabolizing enzymes, drug-efflux pumps, and inflammatory signaling pathways that contribute to adverse drug interactions and anticancer drug resistance. We are also interested in identifying novel small molecules and natural products for their potential to prevent adverse drug interactions and anticancer drug resistance.
Research Interests
- Drug Discovery, Drug Metabolism, Drug Interactions, Chemoresistance, Chemotherapy, Nuclear Receptors, Drug-Metabolizing Enzymes, Drug Transporters
Academic Areas
- Anatomy, Pharmacology, Cancer
Key Words
- Drug Discovery, Drug Metabolism, Drug Interactions, Chemoresistance, Chemotherapy, Nuclear Receptors, Drug-Metabolizing Enzymes, Drug Transporters
